Opioid abuse is one of the most urgent
threats to our nation’s public health and clinicians have felt just as
helpless as their patients about the opioid epidemic mainly because they lacked a baseline metric to properly diagnose patient risk over a wide variety of opioid medications. Fortunately, the CDC has recently
established the Morphine Milligram Equivalent or MME so clinicians are now
able to evaluate a patient’s risk profile across the opioid spectrum. However, to stem the cycle of abuse, misuse, addiction, and overdose, clinicians need more than a standard. They need a system. Introducing FDB’s Opioid Risk Management Module. It’s a cloud-based tool that gives clinicians the data they need to prescribe opioids safely and confidently in compliance with CMS pain
management guidelines. In addition to calculating a patient’s MME, the module provides MME prescribing limit thresholds along with agonist risks such as combining an opioid with a benzodiazepine called a double threat. As well as, combining an opioid with benzodiazepine and muscle relaxants called a triple threat. Best of all, FDB’s Opioid Risk Management Module was created to integrate within a clinician’s workflow. Give clinicians the tool they need to manage their patient’s pain confidently. Give them FDB’s Opioid Risk Management Module.